Par Pharmaceutical signs distribution agreement with AstraZeneca
Par began shipping 0.25mg/2ml and 0.5mg/2ml to the trade. Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.